The SPTA1 gene gives your body instructions for alpha spectrin, a support protein that helps red blood cells keep their shape. This gene helps your body keep these cells flexible so they can squeeze through tiny blood vessels and the spleen without breaking apart. If the gene does not work properly, red blood cells may become fragile or misshapen, which can lead to anemia from early cell breakdown, jaundice, gallstones, or an enlarged spleen. Some people with variants in the SPTA1 gene have inherited red blood cell conditions such as hereditary elliptocytosis or hereditary pyropoikilocytosis.
What is a gene?
A gene is a section of DNA that carries information your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do much of the work. Other genes mainly direct when, where, and how strongly certain processes happen. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
SPTA1Gene function
What if the gene works
The SPTA1 gene helps make alpha spectrin, a protein that supports red blood cells’ outer structure. This helps red blood cells keep their shape and bend as they move through tiny blood vessels and the spleen.
Risk
What if the gene does not work
Variants in the SPTA1 gene can weaken red blood cell structure, causing hemolytic anemia such as hereditary elliptocytosis or, with more severe variants, hereditary pyropoikilocytosis. Effects range from none to anemia, jaundice, and an enlarged spleen.
Treatment
What does that mean for your treatment
No the SPTA1 gene-specific treatment or management approach is currently established, and care is usually guided by the person’s red blood cell symptoms rather than the gene result itself.
Conditions associated with SPTA1
Gene function
What if the gene works
Red blood cells need to be both sturdy and flexible as they travel through the bloodstream. Inside these cells, the SPTA1 gene helps build a thin support layer just under the cell membrane. This layer lets the cells keep their usual shape while bending easily in very small blood vessels.
The SPTA1 gene helps red blood cells keep their usual disc shape. This is part of how the SPTA1 gene helps red blood cells keep their shape during daily circulation.
Its protein forms a flexible inner mesh just under the red blood cell membrane. This supportive layer helps the cell stay sturdy while moving through the bloodstream.
Red blood cells often squeeze through very small blood vessels. The protein from the SPTA1 gene helps them bend and then spring back to their usual shape.
Inside red blood cells, this protein links the membrane to other support proteins. That connection helps keep the cell surface organized and stable.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SPTA1 gene can lower the amount of alpha spectrin made, shorten the protein, or weaken how it folds and links with partner proteins in the red blood cell support mesh. This helps explain how SPTA1 gene variants affect red blood cells at a cellular level. Milder variants may leave some protein function, while more severe variants can make the cell membrane less stable, often leading to earlier or more marked features of hereditary elliptocytosis or hereditary pyropoikilocytosis.
How variants are linked to conditions
Pathogenic variants in the SPTA1 gene can cause inherited red blood cell conditions, including hereditary elliptocytosis, hereditary pyropoikilocytosis, and some forms of hereditary spherocytosis. In practice, SPTA1 gene variants linked to hereditary elliptocytosis and related anemias may lead to anemia, jaundice, gallstones, or an enlarged spleen, although severity varies widely. Some SPTA1 variants can also make another red blood cell condition more severe when they are inherited alongside a second variant.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SPTA1, risk is shaped mainly by the exact gene changes you inherit. Red blood cell problems are more likely or more severe when changes affect both copies of the gene, or when one harmful change is paired with a low-activity SPTA1 version. In people already living with an SPTA1-related condition, infections can sometimes bring on worse anemia or jaundice.
Inheritance of SPTA1 variants
SPTA1 gene variants can be inherited in different ways depending on the specific red blood cell condition they cause. In many families, the SPTA1 gene inheritance pattern is autosomal dominant, which means a parent with the variant can pass it to each child with a 50% chance. Some SPTA1-related conditions follow an autosomal recessive pattern instead, where a child inherits one altered copy from each parent. In practical terms, this means SPTA1 gene variants can pass from either parent to sons or daughters, but the chance of symptoms depends on the exact variant combination.
What does my SPTA1 result mean for my family?
SPTA1 results can have different meanings for relatives because this gene is linked to more than one inherited red blood cell condition. In some families, a changed copy can be passed from parent to child and close relatives may also carry it or have mild anemia-related findings; in others, the condition appears when both copies are changed, which can mean parents are healthy carriers and siblings may also be affected or be carriers. The family impact depends on the exact SPTA1 result.
Genetic information
Genetic testing
How you find out about variants
SPTA1 genetic testing usually uses a blood sample or cheek swab to read the SPTA1 gene for variants. Results may help explain inherited red blood cell conditions and can show whether a variant is linked to disease, likely harmless, or still unclear.
When should I consider getting a genetic test?
Consider genetic testing for the SPTA1 gene if you or your child has ongoing anemia, jaundice, gallstones, or an enlarged spleen along with red blood cells that break easily or look unusually shaped on blood tests. It can also help when these problems run in the family or when doctors are trying to confirm an inherited red blood cell condition.
A genetic result is only one part of your health story
How informative a genetic result is depends on both the condition being considered and the type of variant involved, even though the result itself can provide valuable insight. Over time, how the body works is also shaped by many other factors, including age, lifestyle, environment, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may process it differently because inherited differences can change how the body absorbs, breaks down, or responds to a drug. This is common and can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences affect how people respond to medicines. By studying links between genes and medications, it helps explain why the same treatment can have different effects in different people. With many drugs, genes can influence how powerfully a medicine works or how the body handles it. Understanding this can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SPTA1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so any concerns about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor.
History
SPTA1 entered medical genetics through studies of inherited red blood cell conditions, especially hereditary spherocytosis and hereditary elliptocytosis, during the late 20th century. Researchers first linked problems in the red cell membrane skeleton to alpha spectrin, the protein made from the SPTA1 gene, before the gene itself was fully mapped and characterized. From these first observations, research expanded steadily. As DNA testing improved in the 1990s and 2000s, clinicians could connect specific SPTA1 variants with patterns seen in families and with differences in condition severity. This work helped turn older microscope based descriptions of unusual red blood cells into clearer genetic diagnoses and shaped modern understanding of inherited red blood cell membrane conditions.